Real-World Treatment Patterns in Patients with Spinal Muscular Atrophy Receiving Multiple Disease-Modifying Therapies.

Zolgensma (onasemnogene abeparvovec-xioi) - Novartis

Evrysdi (risdiplam) - Roche

Spinraza (nusinersen) - Biogen

http://www.ncbi.nlm.nih.gov/pubmed/42799810

Dongni Ye; Esteban Lemus Wirtz; John Meehan; Min Yang; Sandra Reyna; Walter Toro Jimenez; Wei Song

Sep 27, 2026